Search

Displaying results 6301 - 6310 of 8411 in total
  1. Drug

    Capsicum annuum whole

    go.drugbank.com/drugs/DB14368
    Investigational

    It is not an approved drug.

  2. Drug

    Branaplam

    go.drugbank.com/drugs/DB14918
    Investigational

    Branaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)).

  3. Drug

    TPX-4589

    go.drugbank.com/drugs/DB18604
    Investigational

    TPX-4589 is an antibody-drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE.

  4. Drug

    Telapristone acetate

    go.drugbank.com/drugs/DB05253
    Investigational

    Telapristone acetate, an orally-available, selective progesterone receptor modulator, is in development to alleviate symptoms associated with both uterine fibroids and endometriosis.

  5. Drug

    IRX-2

    go.drugbank.com/drugs/DB05643
    Investigational

    It is being investigated to promote or enhance an anti-cancer immune response.

  6. Drug

    Amitifadine

    go.drugbank.com/drugs/DB05964
    Investigational

  7. Drug

    H3B-8800

    go.drugbank.com/drugs/DB14017
    Investigational

    H3B-8800 is a novel spliceosome inhibitor developed by H3 Biomedicine . It offers the benefit of preferentially killing spliceosome-mutant cancer cells whereas other splicesome inhibitors, such as the pladienolide analogue E7107, show no...

  8. Drug

    Clinafloxacin

    go.drugbank.com/drugs/DB14025
    Experimental

    However, its approval and release have been halted due to the presence of serious side effects.

    Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C19 Inhibitors
  9. Drug

    Fuzapladib

    go.drugbank.com/drugs/DB19478
    Experimental

    Fuzapladib has a monoisotopic molecular weight of 379.12 Da.

  10. Drug

    Umibecestat

    go.drugbank.com/drugs/DB19898
    Experimental

    Umibecestat has a monoisotopic molecular weight of 513.08 Da.